Results 91 to 100 of about 1,229 (138)
Some of the next articles are maybe not open access.

Kinetics of misonidazole enantiomers

Clinical Pharmacology and Therapeutics, 1984
The kinetics of misonidazole enantiomers were followed in nine healthy subjects after a single oral dose of racemic misonidazole (1.0 gm/m2). Mean clearance of (+)-misonidazole was 14% greater than that for (-)-misonidazole and mean volume of distribution was slightly greater (3%) for the (+)-enantiomer.
openaire   +2 more sources

Radiation-Enhanced Cytotoxicity of Misonidazole

Radiation Research, 1981
KORBELIK, M., PALCIC, B., AND SKARSGARD, L. D. Radiation-Enhanced Cytotoxicity of Misonidazole. Radiat. Res. 88, 343-353 (1981). The effect of ionizing radiation on the toxicity of misonidazole to hypoxic mammalian cells was examined. Cell toxicity response (log surviving fraction vs time of exposure to misonidazole in hypoxia) can be approximated by a
M, Korbelik, B, Palcic, L D, Skarsgard
openaire   +2 more sources

Misonidazole

2000
Abstract Misonidazole, a 2-nitroimidazole compound, is a hypoxic cell radiosensitizer used to sensitize radioresistant tumor cells. Neurotoxicity consists of a dose-limiting, predominantly sensory peripheral neuropathy and, at high doses, encephalopathy.
openaire   +1 more source

Chemosensitization of mouse tumors by misonidazole

International Journal of Radiation Oncology*Biology*Physics, 1982
The chemosensitizing action of misonidazole when used in combination with chemotherapeutic drugs has been assessed in two mouse tumors. Regrowth delay has been used as the assay, and by producing dose-response curves the effect has been classified as additive or interactive. A very small additive effect was seen with bleomycin and adriamycin.
V S, Randhawa, F A, Stewart, J, Denekamp
openaire   +2 more sources

Electroneurographic Investigations of Misonidazole Polyneuropathy

European Neurology, 2008
13 patients with malignant tumors were treated by the radiosensitizer misonidazole (Ro 07–0582), total dosage 20–29 g. The electrophysiological investigations showed (1) an early increase of distal latency, the motor nerve conduction velocity (NCV) of the peroneal nerve and the NCV of the sural nerve remaining normal or only slightly reduced, and in a ...
B, Mamoli   +4 more
openaire   +2 more sources

Glutathione Depletion and Misonidazole Efficiency

The British Journal of Radiology, 1985
Shrieve and Denekamp (1985) conclude that misonidazole (MISO) is not more efficient in GSH-depleted cells than in untreated cells. They point out that although their experimental studies on the radiosensitisation of GSH-depleted hypoxic cells by oxygen or MISO (Shrieve et al, 1984) are similar to those of others in the literature, their conclusion is ...
J M, Brown, E A, Bump
openaire   +2 more sources

Misonidazole and potentially lethal damage

International Journal of Radiation Oncology*Biology*Physics, 1982
The existence of potentially lethal damage (PLD) is demonstrated in exponentially growing CHO cells exposed to misonidazole in hypoxia. The method of hypertonic post-treatment of cells was used in these studies. Misonidazole-induced PLD differs in many characteristics from radiation-induced PLD.
M, Korbelik   +3 more
openaire   +2 more sources

Flash Photolysis of Misonidazole and Metronidazole

International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1987
Laser flash photolysis at 355 nm of misonidazole or metronidazole in aqueous solutions produced the relatively long-lived nitro radical anion as the only observable transient species. When 266 nm excitation was used, a small yield of solvated electron was observed.
openaire   +2 more sources

The Radiation Reduction of Misonidazole

Radiation Research, 1981
[14C]Misonidazole, a 2-nitroimidazole radiation sensitizer, was reduced in dilute aqueous solution by irradiation in the absence of oxygen and in the presence of excess formate ions. In solutions buffered at pH 7.0 the misonidazole absorption spectrum is lost with increasing radiation exposure, consuming 4.0 + 0.2 reducing equivalents per molecule ...
D. W. Whillans, G. F. Whitmore
openaire   +1 more source

Misonidazole neuropathy.

Acta neurologica Scandinavica. Supplementum, 1984
Neurotoxic side effects of misonidazole with peripheral neuropathy was investigated in two series of patients. The first series consisted of eight patients with carcinoma of the pharynx, larynx or lung who, during treatment with misonidazole, developed peripheral neuropathy dominated by severe sensory symptoms and signs localized mainly to the lower ...
Paulson, O B   +8 more
openaire   +1 more source

Home - About - Disclaimer - Privacy